EPISODE · Sep 7, 2021 · 14 MIN
ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation - report from ESC2021
from Medical Digest & Congress Report · host Medical Congress News
Prof. George Dangas speaks about the outcomes of the ENVISAGE-TAVI AF trial. Video: https://congressreport.eu/scientific-contents/interview:envisage-tavi-af-edoxaban-vs-vitamin-k-antagonists-after-tavi-patients-atrial-fibrillation
Embed this episode
Ready to play
ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation - report from ESC2021
No transcript for this episode yet
Similar Episodes
No similar episodes found.